| Dr Christopher P Wojcik, DO | |
|
1635 Aurora Ct, Aurora, CO 80045-2541 | |
| (303) 724-5918 | |
| Not Available |
| Full Name | Dr Christopher P Wojcik |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1635 Aurora Ct, Aurora, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083350508 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | TL.0009184 (Colorado) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | TL.0009184 (Colorado) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher P Wojcik, DO 25012 Blakely Dr, Plainfield, IL 60585-7863 Ph: (815) 342-9472 | Dr Christopher P Wojcik, DO 1635 Aurora Ct, Aurora, CO 80045-2541 Ph: (303) 724-5918 |
News Archive
That is down about 2 million from an earlier projection by the nonpartisan Congressional Budget Office, reflecting the calculation that more of the nation's 30 million uninsured will qualify for exemptions under the law.
Adamas Pharmaceuticals, an emerging pharmaceutical company focused on developing small-molecule therapeutics to treat neurological and infectious diseases, selected Veeva System's VBioPharma™ KOL Edition – part of the Veeva CRM suite. Selection of Veeva's SaaS solution marks an important step in Adamas' early-stage product commercialization strategy.
StemCells, Inc. announced today that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009.
Biogen Idec and Swedish Orphan Biovitrum (Sobi) released data that confirmed the ability of investigational recombinant factors VIII Fc fusion protein (rFVIIIFc) and IX Fc fusion protein (rFIXFc) to provide long-lasting protection from bleeding with fewer injections than are required with the current standard of care for people with hemophilia.
The Virginia Commonwealth University Mood Disorders Institute is recruiting participants for a national study of a new treatment method for premenstrual dysphoric disorder, a severe and debilitating form of premenstrual syndrome, or PMS.
› Verified 6 days ago
Kevin Bradley Rothchild, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-2728 Fax: 303-724-2761 | |
Dr. Juan Pablo Idrovo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-8366 | |
Gregory Stiegmann, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Nathan W. Pearlman, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 303-724-2728 Fax: 303-724-2733 | |
Mr. Julian Simon Winocour, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1635 Aurora Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Jonathan Roach, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Peter T Kennealey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |